Navigation Links
Neuromonics Unveils New Device to Relieve Mild, Moderate Tinnitus at Audiology NOW!
Date:3/28/2013

Bethlehem, PA (PRWEB) March 28, 2013

Neuromonics, Inc., is introducing the first device specifically designed to help individuals suffering from mild to moderate tinnitus.

The Neuromonics Sanctuary™ device is the company’s newest product to help tinnitus patients. The company will debut the Sanctuary at the Audiology NOW! Conference April 3-6 in Anaheim, Calif., at Booth No. 1660. Neuromonics also will showcase its Oasis, the FDA-cleared, patented and clinically proven device that offers long-term, significant relief for serious tinnitus sufferers. “With the addition of the Sanctuary, Neuromonics can provide effective, simple treatment for the full range of those dealing with tinnitus,” says Curtis Amann, vice president of marketing and sales for the company.

Tinnitus is often described as buzzing, ringing, hissing, humming, roaring, or whistling that someone hears in the absence of any external sound. More than 50 million people in the United States alone suffer from the condition, according to the American Tinnitus Association. Usually brought on by exposure to loud noise, the problem is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from tinnitus.

The Neuromonics Sanctuary provides relief of tinnitus symptoms by combining relaxing music with a customized neural stimulus. The Sanctuary blends a customized, high-frequency signal with music, providing an on-demand sense of control and relief to the individual. Patients with mild or moderate tinnitus disturbance can experience relief within minutes of their tinnitus assessment, according to Amann.

Ease of use
The compact Sanctuary device is simple to use, functioning much like familiar consumer music players, and fits easily into patients’ lifestyles, says Amann. Tinnitus sufferers can choose from one of three pre-programmed profiles to find the signal that provides the greatest degree of relief from their particular symptoms. Pressing “play” allows them to listen to calming, relaxing music that interacts with the tinnitus perception.

Individuals use the Sanctuary at times when their tinnitus is bothersome, says Amann. “The Sanctuary provides relief while listening to the device -- when you want it and when you need it.”

Tinnitus sufferers can begin to determine if the Sanctuary is the right choice for them by taking Neuromonics’ online tinnitus assessment. A trained audiology clinician will review the score during an assessment visit and determine if the Sanctuary is the appropriate device. The Neuromonics Sanctuary is a Class II medical device, regulated by the FDA and requiring a prescription from a trained clinician.

Key features
The Sanctuary is not a masking device, but rather works to promote new neural connections that will allow the brain to help filter out the tinnitus perception. Key features of the simple device include the following.

  •     Simple setup and same-day fitting
  •     User-friendly interface
  •     Sleep timer
  •     Multiple headphone options
  •     Bedside speaker accesory

Long-term tinnitus relief
The Neuromonics Sanctuary device works with the same principles as the Neuromonics Oasis, the gold standard for long-term reduction of tinnitus disturbance and awareness. The Sanctuary is designed for situational relief. In contrast, the FDA-cleared, patented and clinically proven Neuromonics Oasis, in combination with the Neuromonics Tinnitus Treatment, is a long-term treatment program for those with more severe tinnitus.

Neuromonics, Inc. (http://www.neuromonics.com)
Based in Bethlehem, Pa., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The Sanctuary provides situational relief for those suffering from mild to moderate tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term significant relief for those with severe tinnitus. With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. The treatment has been featured on national news media including The Doctors and CNN.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10574661.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. IQware Solutions Unveils New Website, New Corporate Identity
2. CustomerCentric Selling® Unveils New Client Testimonial Videos to Showcase Significant Sales Success
3. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
4. 'EMT Exam Ace' Unveils Free Sample EMT Practice Quizzes
5. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
6. Naturel Collagen Canada Unveils C RUM, the Newest Addition to the Revolutionary Natural Collagen Skin Care Product Line
7. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
8. Garden Media Unveils 2013-14 Garden Trends: ‘Finding Bliss in the Garden’- Part 3
9. Garden Media Group Unveils New Marketing and Public Relations Blog, GROW
10. Physicians Indemnity Risk Retention Group Unveils New Website
11. Marketing Xocolate International Corporation (MXI Corp) Unveils New Healthy Dark Chocolate Product: Xoçai™ Nuggets, Which Are Both Diabetic And Vegan Friendly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders ... significant number of women and men with eating disorders report a history of ... predicts the development of an eating disorder. , At the 2016 iaedp ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... this important news! AHCC and the Home Health and Hospice ICD-10 Transition Workgroup ... for official ICD coding guidance and clarifications, to address concerns over the use ...
(Date:2/8/2016)... ... ... The schedule is now online for the largest and most ... being held May 25-29 at the Loews Chicago O’Hare Hotel, continues to give the ... chronic illness in children. , Very recent articles have cited 1 child in 20 ...
(Date:2/7/2016)... Dallas, Texas (PRWEB) , ... February 07, 2016 ... ... its new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and ... , MyDecision™ combines three elements to cut the cost of providing employee healthcare ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Avista Pharma Solutions ... Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer ... years of experience in various roles within growing technology ... he served as the Executive Director of Finance at ... Raleigh, NC . Previously, Mr. Setzer ...
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 /PRNewswire/ ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ... has announced the addition of the ... - Global Forecasts to 2020" report ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
Breaking Medicine Technology: